RAPS Convergence 2025

이벤트:

The largest annual gathering of regulatory professionals brings together leaders to advance high-impact regulatory science and practice. Novotech’s Drug Development Consulting team will be on site to discuss regulatory strategy, risk-based approaches, and inclusive trial design, helping sponsors align programs with evolving expectations and accelerate decision-making.

Attendees:

• Scott Schliebner — Global Head, Drug Development Consulting.
• Ingrid Leth — Senior Scientific Consultant.

Speaker & Presentation:

Scott Schliebner will present on “Enhancing Understanding of Biologic Variability Through Representation in Clinical Trials”

Date/Time: October 8, 9:15–10:30 a.m.

Please join the session, and if you’d like to connect with our team at the conference, please fill out the form on this page to request a meeting.